Bisimilars Learning Toolkit
Biosimilar Development Process
Biological products that are demonstrated to be biosimilar to or interchangeable with an FDA-approved biological product
- Abbreviated pathway to provide more treatment options, increase access, lower costs
- Rigorous approval standards for safety and effectiveness
- Ten biosmilars approved to date
Learning toolkit to help promote understanding of biosimilars and interchangeable products
Image credit: FDA